Legacy Wealth Asset Management, LLC Bio Techne Corp Transaction History

Legacy Wealth Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$62.12 - $84.15 $62,120 - $84,150	-1,000 Reduced 25.26%	2,959 $212,000
Q1 2024 Apr 19, 2024	SELL	$65.98 - $77.09 $224,793 - $262,645	-3,407 Reduced 46.25%	3,959 $278,000
Q4 2023 Jan 10, 2024	SELL	$52.83 - $78.22 $3,698 - $5,475	-70 Reduced 0.94%	7,366 $568,000
Q3 2023 Oct 31, 2023	SELL	$67.52 - $89.42 $101,280 - $134,130	-1,500 Reduced 16.79%	7,436 $506,000
Q2 2023 Aug 04, 2023	SELL	$73.76 - $85.98 $92,716 - $108,076	-1,257 Reduced 12.33%	8,936 $729,000
Q1 2023 Apr 21, 2023	SELL	$71.62 - $86.62 $96,758 - $117,023	-1,351 Reduced 11.7%	10,193 $756,000
Q4 2022 Feb 02, 2023	BUY	$80.67 - $352.29 $686,824 - $3 Million	8,514 Added 280.99%	11,544 $956,000
Q3 2022 Oct 14, 2022	SELL	$282.54 - $391.85 $98,889 - $137,147	-350 Reduced 10.36%	3,030 $861,000
Q2 2022 Jul 19, 2022	SELL	$322.67 - $449.65 $48,400 - $67,447	-150 Reduced 4.25%	3,380 $1.17 Million
Q1 2022 May 12, 2022	BUY	$353.85 - $487.79 $1.25 Million - $1.72 Million	3,530 New	3,530 $1.53 Million

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Legacy Wealth Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Legacy Wealth Asset Management, LLC with notifications on news.